EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?

Satoka Fujimoto iD, Atsushi Fujimoto iD, Catherine Elorette iD, Ki Sueng Choi iD, Helen Mayberg iD, Brian Russ, Peter Rudebeck iD

Neuropsychopharmacology · 2025

DOI: 10.1038/s41386-024-01976-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuropsychopharmacology, 2025. Verfasst von Satoka Fujimoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Hauptthemen laut MEDLINE: Mental Disorders, Brain, Neuroimaging. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Brain and Behavior Research Foundation (Brain & Behavior Research Foundation), NINDS NIH HHS, U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuromodulation is increasingly becoming a therapeutic option for treatment resistant psychiatric disorders. These non-invasive and invasive therapies are still being refined but are clinically effective and, in some cases, provide sustained symptom reduction. Neuromodulation relies on changing activity within a specific brain region or circuit, but the precise mechanisms of action of these therapies, is unclear. Here we review work in both humans and animals that has provided insight into how therapies such as deep brain and transcranial magnetic stimulation alter neural activity across the brain. We focus on studies that have combined neuromodulation with neuroimaging such as PET and MRI as these measures provide detailed information about the distributed networks that are modulated and thus insight into both the mechanisms of action of neuromodulation but also potentially the basis of psychiatric disorders. Further we highlight work in nonhuman primates that has revealed how neuromodulation changes neural activity at different scales from single neuron activity to functional connectivity, providing key insight into how neuromodulation influences the brain. Ultimately, these studies highlight the value of combining neuromodulation with neuroimaging to reveal the mechanisms through which these treatments influence the brain, knowledge vital for refining targeted neuromodulation therapies for psychiatric disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mental DisordersBrainNeuroimagingHumansAnimalsDeep Brain StimulationTranscranial Magnetic StimulationNeurotransmitter Agents

Substanzen

Neurotransmitter Agents

Autor:innen und Institutionen

  • Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Lipschultz Center for Cognitive Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Nash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Departments of Radiology and Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Department of Neurology and Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. brian.russ@nki.rfmh.org.

ORCID-Profile: Satoka Fujimoto, Atsushi Fujimoto, Catherine Elorette, Ki Sueng Choi, Helen Mayberg, Peter Rudebeck

Förderung

  • Brain and Behavior Research Foundation (Brain & Behavior Research Foundation)
  • NINDS NIH HHS
  • U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
  • NIMH NIH HHS
  • Hope for Depression Research Foundation (Depression Research Foundation)
  • U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)

Zitieren

APA

Fujimoto, S., Fujimoto, A., Elorette, C., Choi, K. S., Mayberg, H., Russ, B., & Rudebeck, P. (2025). What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?. Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-01976-2

Vancouver

Fujimoto S, Fujimoto A, Elorette C, Choi KS, Mayberg H, Russ B, et al. What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?. Neuropsychopharmacology. 2025. doi:10.1038/s41386-024-01976-2

BibTeX
@article{Fujimoto2025,
  author = {Fujimoto, Satoka and Fujimoto, Atsushi and Elorette, Catherine and Choi, Ki Sueng and Mayberg, Helen and Russ, Brian and Rudebeck, Peter},
  title = {What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?},
  journal = {Neuropsychopharmacology},
  year = {2025},
  doi = {10.1038/s41386-024-01976-2}
}
Kostenlos starten →